The impacted brands include CVS Health and Equate, which is sold at Walmart. More specifically, CVS Health: Infants' Ibuprofen Concentrated Oral Suspension sold in both 1.0 oz and 0.5 oz bottles, according to the U.S. Food and Drug Administration's (FDA) notice, have been added to the list.
Walmart sells the recalled product under the "Equate" label and the National Drug Code (NDC) 49035-125-23; the products being withdrawn have the lot numbers 00717005A, 00717009A, 00717015A and 00717024A on their label.More news: Govt doubles tax exemption for the middle class man
The company says there is a "remote possibility" that infants more susceptible to medication with a higher potency of ibuprofen might suffer permanent renal injury.
Tri Pharma says some of the bottles in the recalled lots have ibuprofen up to 10 percent over the limit, but that's far below the seven times dosage that's considered unquestionably unsafe for a baby. Normal levels are 50 mg per 1.25 mL.
Adverse effects that could be experienced include nausea, vomiting, epigastric pain, or more rarely diarrhea.More news: DA joins nation in mourning loss of three Hoerskool Driehoek pupils
Infants' Ibuprofen Concentrated Oral Suspension sold at Walmart, with expiration dates of February 2019, April 2019 and August 2019.
CVS Health: Infants' Ibuprofen Concentrated Oral Suspension in half-ounce bottles, lot Nos. As of Tuesday, no serious adverse reactions had been reported related to the recall, the company said. Lot numbers: 00717006A, 00717024A and 4718. At CVS, the previously recalled lot is 00717024A (expires 08/19).More news: Prince William And Kate Middleton Will Attend The 2019 BAFTAs